艾意凯咨询：2026生物制药企业的制胜之道：L.E.K.洞察：创新、增长与核心竞争力研究报告（英文版）（117页）.pdf

1、English EditionThe Biopharma Imperative L.E.K.Insights on Innovation,Growth,andCompetitive AdvantageForewordThis collection brings together a focused selection of L.E.K.Consultings perspectives on the forces reshaping life sciences and biopharma.The sector continues to push at the boundaries of scie

2、ntific possibility while navigating capital constraints,accelerating competition and rising expectations from patients,regulators and investors.The pieces included here examine those pressures with clarity and offer practical guidance on how leaders can respond with confidence.Our insights highlight

3、 the strategic consequences of rapid advances in areas such as radiotherapeutics,nextgeneration oncology partnerships,AI and quantum computing.We also explore the commercial realities facing organisations as they compete in fastmoving therapeutic markets,reassess portfolio priorities,raise R&D produ

4、ctivity and operate in a more selective funding environment.Across these topics,a consistent message emerges:competitive advantage will rest with organisations that pair scientific ambition with disciplined decisionmaking and operational focus.At L.E.K.,we help clients interpret change and convert i

5、t into decisive action.By distilling market signals,emerging opportunities and the pressure points that matter most,this collection offers leaders a clear view of what it takes to steer successfully through a period of structural shifts.Helen ChenGlobal Sector Co-Head for Healthcare Greater China Ma

6、naging PartnerI L.E.K.ConsultingContents?1.2.3.4.5.6.7.8.9.10.?ContentsAbout L.E.K.Consulting?11.12.13.?EXECUTIVE INSIGHTS?R&D productivity stands as one of the most critical issues for biopharma executives,as it directly addresses the ability to transform pipeline investments into tangible revenue